DGAP-News: Cannovum AG enters cannabis market segment Dronabinol
Cannovum AG (stock markets Dsseldorf, Mnchen, Hamburg, Berlin, gettex: ISIN DE000A2LQU21) is pleased to announce a strategic supply partnership for Dronabinol with a European medical cannabis supplier.
- Cannovum AG (stock markets Dsseldorf, Mnchen, Hamburg, Berlin, gettex: ISIN DE000A2LQU21) is pleased to announce a strategic supply partnership for Dronabinol with a European medical cannabis supplier.
- Cannovum is expanding its medical cannabis portfolio by adding Dronabinol through its licensed subsidiary, Cannovum Health eG.
- Cannabis extracts are to follow next," says Pia Marten, CEO of Cannovum AG.
- Through its subsidiary Cannovum Health eG, Cannovum is a fully licensed pharmaceutical wholesaler, importer and manufacturer of high-quality medical cannabis products based in Berlin.